Noninvasive biomarkers of endometriosis: myth or reality?

References

• Rogers PA, D’Hooghe TM, Fazleabas A, et al. Defining. future directions for endometriosis research: workshop report from the 2011 World Congress of Endometriosis In Montpellier, France. Reprod Sci 2013;20(5):483-99
   PubMed Web of Science ®Google Scholar
• Guo SW, Wang Y. Sources of heterogeneities in estimating the prevalence of endometriosis in infertile and previously fertile women. Fertil Steril 2006;86(6):1584-95
   PubMed Web of Science ®Google Scholar
• Adamson GD, Kennedy S, Hummelshoj L. Creating solutions in endometriosis: global collaboration through the World Endometriosis Research Foundation. J Endometriosis 2010;2:3
   Google Scholar
• Brosens I, Benagiano G. Endometriosis, a modern syndrome. Indian J Med Res 2011;133:581-93
   PubMed Web of Science ®Google Scholar
• Jacques D, Oliver D, Jean-Christophe L, Jean S. Peritoneal, Ovarian, and Rectovaginal Endometriosis are Three Different Entities. In: Giudice LC, Evers JLH, Healy DL, Editors. Endometriosis Science and Practice. Willey-Blackwell A John Willey and Sons Ltd., Singapore Markono Print Media Pte Ltd, 2012;92-108
   Google Scholar
• Hsu AL, Khachikyan I, Stratton P. Invasive and noninvasive methods for the diagnosis of endometriosis. Clin Obstet Gynecol 2010;53(2):413-19
   PubMed Web of Science ®Google Scholar
• Antonio B, Diane D, Anne G, Marco A. Extra-Abdominal Endometriosis. In: Giudice LC, Evers JLH, Healy DL, Editors. Endometriosis Science and Practice. Willey-Blackwell A John Willey and Sons Ltd., Singapore Markono Print Media Pte Ltd, 2012;108-17
   Google Scholar
• Burney RO, Giudice LC. Pathogenesis and pathophysiology of endometriosis. Fertil Steril 2012;98(3):511-19
   PubMed Web of Science ®Google Scholar
• Nap AW. Theories on the Pathogenesis of Endometriosis. In: Giudice LC, Evers JLH, Healy DL, Editors. Endometriosis Science and Practice. Wiley-Blackwell A John Wiley and Sons, Ltd. Publication, Singapore, 2012;42-53
   Google Scholar
• May KE, Conduit-Hulbert SA, Villar J, et al. Peripheral biomarkers of endometriosis: a systematic review. Hum Reprod Update 2010;16(6):651-74
   PubMed Web of Science ®Google Scholar
• Walter AJ, Hentz JG, Magtibay PM, et al. Endometriosis: correlation between histologic and visual findings at laparoscopy. Am J Obstet Gynecol 2001;184(7):1407-11. discussion 1411-1403
   PubMed Web of Science ®Google Scholar
• Balasch J, Creus M, Fábregues F, et al. Visible and non-visible endometriosis at laparoscopy in fertile and infertile women and in patients with chronic pelvic pain: a prospective study. Hum Reprod 1996;11(2):387-91
   PubMed Web of Science ®Google Scholar
• Nnoaham KE, Hummelshoj L, Webster P, et al. Impact of endometriosis on quality of life and work productivity: a multicenter study across ten countries. Fertil Steril 2011;96(2):366-73. e368
   PubMed Web of Science ®Google Scholar
• Simoens S, Dunselman G, Dirksen C, et al. The burden of endometriosis: costs and quality of life of women with endometriosis and treated in referral centres. Hum Reprod 2012;27(5):1292-9
   PubMed Web of Science ®Google Scholar
• Ballard K, Lowton K, Wright J. What’s the delay? A qualitative study of women’s experiences of reaching a diagnosis of endometriosis. Fertil Steril 2006;86(5):1296-301
   PubMed Web of Science ®Google Scholar
• Guo SW. Recurrence of endometriosis and its control. Hum Reprod Update 2009;15(4):441-61
   PubMed Web of Science ®Google Scholar
• Chamié LP, Blasbalg R, Pereira RM, et al. Findings of pelvic endometriosis at transvaginal US, MR imaging, and laparoscopy. Radiographics 2011;31(4):E77-100
   PubMed Web of Science ®Google Scholar
• Grasso RF, Di Giacomo V, Sedati P, et al. Diagnosis of deep infiltrating endometriosis: accuracy of magnetic resonance imaging and transvaginal 3D ultrasonography. Abdom Imaging 2010;35(6):716-25
   PubMedGoogle Scholar
• Fassbender A, Vodolazkaia A, Saunders P, et al. Biomarkers of endometriosis. Fertil Steril 2013;99(4):1135-45
   PubMed Web of Science ®Google Scholar
• Meuleman C, Vandenabeele B, Fieuws S, et al. High prevalence of endometriosis in infertile women with normal ovulation and normospermic partners. Fertil Steril 2009;92(1):68-74
   PubMed Web of Science ®Google Scholar
• Biomarkers Definitions Working Group. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 2001;69(3):89-95
   PubMed Web of Science ®Google Scholar
• Whiting PF, Rutjes AW, Westwood ME, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 2011;155(8):529-36
   PubMed Web of Science ®Google Scholar
• Whiting P, Rutjes AW, Reitsma JB, et al. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 2003;3:25
   PubMedGoogle Scholar
• Jackson DH, Banks RE. Banking of clinical samples for proteomic biomarker studies: a consideration of logistical issues with a focus on pre-analytical variation. Proteomics Clin Appl 2010;4(3):250-70
   PubMed Web of Science ®Google Scholar
• Huhtinen K, Suvitie P, Hiissa J, et al. Serum HE4 concentration differentiates malignant ovarian tumours from ovarian endometriotic cysts. Br J Cancer 2009;100(8):1315-19
   PubMed Web of Science ®Google Scholar
• Szubert M, Suzin J, Wierzbowski T, Kowalczyk-Amico K. CA-125 concentration in serum and peritoneal fluid in patients with endometriosis – preliminary results. Arch Med Sci 2012;8(3):504-8
   PubMed Web of Science ®Google Scholar
• Vodolazkaia A, Bossuyt X, Fassbender A, et al. A high sensitivity assay is more accurate than a classical assay for the measurement of plasma CRP levels in endometriosis. Reprod Biol Endocrinol 2011;9:113
   PubMed Web of Science ®Google Scholar
• Ramos IM, Podgaec S, Abrao MS, et al. Evaluation of CA-125 and soluble CD-23 in patients with pelvic endometriosis: a case-control study. Rev Assoc Med Bras 2012;58(1):26-32
   PubMed Web of Science ®Google Scholar
• Tokmak A, Ugur M, Tonguc E, et al. The value of urocortin and Ca-125 in the diagnosis of endometrioma. Arch Gynecol Obstet 2011;283(5):1075-9
   PubMed Web of Science ®Google Scholar
• Reis FM, Luisi S, Abrao MS, et al. Diagnostic value of serum activin A and follistatin levels in women with peritoneal, ovarian and deep infiltrating endometriosis. Hum Reprod 2012;27(5):1445-50
   PubMed Web of Science ®Google Scholar
• Kocbek V, Vouk K, Mueller MD, et al. Elevated glycodelin-A concentrations in serum and peritoneal fluid of women with ovarian endometriosis. Gynecol Endocrinol 2013;29(5):455-9
   PubMed Web of Science ®Google Scholar
• Mohamed ML, El Behery MM, Mansour SA. Comparative study between VEGF-A and CA-125 in diagnosis and follow-up of advanced endometriosis after conservative laparoscopic surgery. Arch Gynecol Obstet 2013;287(1):77-82
   PubMed Web of Science ®Google Scholar
• Chen L, Fan R, Huang X, et al. Reduced levels of serum pigment epithelium-derived factor in women with endometriosis. Reprod Sci 2012;19(1):64-9
   PubMed Web of Science ®Google Scholar
• Li J, Dowdy S, Tipton T, et al. HE4 as a biomarker for ovarian and endometrial cancer management. Expert Rev Mol Diagn 2009;9(6):555-66
   PubMed Web of Science ®Google Scholar
• Van Gorp T, Cadron I, Despierre E, et al. HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm. Br J Cancer 2011;104(5):863-70
   PubMed Web of Science ®Google Scholar
• Eisenberg VH, Zolti M, Soriano D. Is there an association between autoimmunity and endometriosis? Autoimmun Rev 2012;11(11):806-14
   PubMed Web of Science ®Google Scholar
• Young VJ, Brown JK, Saunders PT, Horne AW. The role of the peritoneum in the pathogenesis of endometriosis. Hum Reprod Update 2013;19(5):558-69
   PubMed Web of Science ®Google Scholar
• Nabeta M, Abe Y, Kagawa L, et al. Identification of anti-α-enolase autoantibody as a novel serum marker for endometriosis. Proteomics Clin Appl 2009;3(10):1201-10
   PubMed Web of Science ®Google Scholar
• Nabeta M, Abe Y, Haraguchi R, et al. Serum anti-PDIK1L autoantibody as a novel marker for endometriosis. Fertil Steril 2010;94(7):2552-7. e2551
   PubMed Web of Science ®Google Scholar
• Nabeta M, Abe Y, Takaoka Y, et al. Identification of anti-syntaxin 5 autoantibody as a novel serum marker of endometriosis. J Reprod Immunol 2011;91(1-2):48-55
   PubMed Web of Science ®Google Scholar
• Yi YC, Wang SC, Chao CC, et al. Evaluation of serum autoantibody levels in the diagnosis of ovarian endometrioma. J Clin Lab Anal 2010;24(5):357-62
   PubMed Web of Science ®Google Scholar
• Gajbhiye R, Sonawani A, Khan S, et al. Identification and validation of novel serum markers for early diagnosis of endometriosis. Hum Reprod 2012;27(2):408-17
   PubMed Web of Science ®Google Scholar
• Mihalyi A, Gevaert O, Kyama CM, et al. Non-invasive diagnosis of endometriosis based on a combined analysis of six plasma biomarkers. Hum Reprod 2010;25(3):654-64
   PubMed Web of Science ®Google Scholar
• Socolov R, Butureanu S, Angioni S, et al. The value of serological markers in the diagnosis and prognosis of endometriosis: a prospective case-control study. Eur J Obstet Gynecol Reprod Biol 2011;154(2):215-17
   PubMed Web of Science ®Google Scholar
• Drosdzol-Cop A, Skrzypulec-Plinta V. Selected cytokines and glycodelin A levels in serum and peritoneal fluid in girls with endometriosis. J Obstet Gynaecol Res 2012;38(10):1245-53
   PubMed Web of Science ®Google Scholar
• Vodolazkaia A, El-Aalamat Y, Popovic D, et al. Evaluation of a panel of 28 biomarkers for the non-invasive diagnosis of endometriosis. Hum Reprod 2012;27(9):2698-711
   PubMed Web of Science ®Google Scholar
• Anastasi E, Granato T, Falzarano R, et al. The use of HE4, CA125 and CA72-4 biomarkers for differential diagnosis between ovarian endometrioma and epithelial ovarian cancer. J Ovarian Res 2013;6(1):44
   PubMed Web of Science ®Google Scholar
• Becker CM, Louis G, Exarhopoulos A, et al. Matrix metalloproteinases are elevated in the urine of patients with endometriosis. Fertil Steril 2010;94(6):2343-6
   PubMed Web of Science ®Google Scholar
• El-Kasti MM, Wright C, Fye HK, et al. Urinary peptide profiling identifies a panel of putative biomarkers for diagnosing and staging endometriosis. Fertil Steril 2011;95(4):1261-6
   PubMed Web of Science ®Google Scholar
• Fassbender A, Waelkens E, Verbeeck N, et al. Proteomics analysis of plasma for early diagnosis of endometriosis. Obstet Gynecol 2012;119(2 Pt 1):276-85
   PubMed Web of Science ®Google Scholar
• Long X, Jiang P, Zhou L, Zhang W. Evaluation of novel serum biomarkers and the proteomic differences of endometriosis and adenomyosis using MALDI-TOF-MS. Arch Gynecol Obstet 2013;288(1):201-5
   PubMed Web of Science ®Google Scholar
• Zheng N, Pan C, Liu W. New serum biomarkers for detection of endometriosis using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. J Int Med Res 2011;39(4):1184-92
   PubMed Web of Science ®Google Scholar
• Tokushige N, Markham R, Crossett B, et al. Discovery of a novel biomarker in the urine in women with endometriosis. Fertil Steril 2011;95(1):46-9
   PubMed Web of Science ®Google Scholar
• Cho S, Choi YS, Yim SY, et al. Urinary vitamin D-binding protein is elevated in patients with endometriosis. Hum Reprod 2012;27(2):515-22
   PubMed Web of Science ®Google Scholar
• Mendrick DL. Transcriptional profiling to identify biomarkers of disease and drug response. Pharmacogenomics 2011;12(2):235-49
   PubMed Web of Science ®Google Scholar
• Olmos D, Brewer D, Clark J, et al. Prognostic value of blood mRNA expression signatures in castration-resistant prostate cancer: a prospective, two-stage study. Lancet Oncol 2012;13(11):1114-24
   PubMed Web of Science ®Google Scholar
• Daniela D. Molecular Mechanisms Underlying Endometriosis and Endometriosis-Related Cancer. In: Giudice LC, Evers JLH, Healy DL, Editors. Endometriosis Science and Practice. Willey-Blackwell A John Willey and Sons Ltd., Singapore Markono Print Media Pte Ltd 2012;512-19
   Google Scholar
• De Sanctis P, Elmakky A, Farina A, et al. Matrix metalloproteinase-3 mRNA: a promising peripheral blood marker for diagnosis of endometriosis. Gynecol Obstet Invest 2011;71(2):118-23
   PubMed Web of Science ®Google Scholar
• Mabrouk M, Elmakky A, Caramelli E, et al. Performance of peripheral (serum and molecular) blood markers for diagnosis of endometriosis. Arch Gynecol Obstet 2012;285(5):1307-12
   PubMed Web of Science ®Google Scholar
• miRBase. Available from: http://mirbase.org
   Google Scholar
• Teague EM, Print CG, Hull ML. The role of microRNAs in endometriosis and associated reproductive conditions. Hum Reprod Update 2010;16(2):142-65
   PubMed Web of Science ®Google Scholar
• Mitchell PS, Parkin RK, Kroh EM, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 2008;105(30):10513-18
   PubMed Web of Science ®Google Scholar
• Madhavan D, Cuk K, Burwinkel B, Yang R. Cancer diagnosis and prognosis decoded by blood-based circulating microRNA signatures. Front Genet 2013;4:116
   PubMedGoogle Scholar
• Suryawanshi S, Vlad AM, Lin HM, et al. Plasma microRNAs as novel biomarkers for endometriosis and endometriosis-associated ovarian cancer. Clin Cancer Res 2013;19(5):1213-24
   PubMed Web of Science ®Google Scholar
• Wang WT, Zhao YN, Han BW, et al. Circulating microRNAs identified in a genome-wide serum microRNA expression analysis as noninvasive biomarkers for endometriosis. J Clin Endocrinol Metab 2013;98(1):281-9
   PubMed Web of Science ®Google Scholar
• Li LA, Wang N, Liang TT, et al. [Establishment of serum peptidome pattern-based diagnostic model of endometriosis]. Nan Fang Yi Ke Da Xue Xue Bao 2010;30(4):851-4
   PubMedGoogle Scholar
• Patti GJ, Yanes O, Siuzdak G. Innovation: metabolomics: the apogee of the omics trilogy. Nat Rev Mol Cell Biol 2012;13(4):263-9
   PubMed Web of Science ®Google Scholar
• Xia J, Broadhurst DI, Wilson M, Wishart DS. Translational biomarker discovery in clinical metabolomics: an introductory tutorial. Metabolomics 2013;9(2):280-99
   PubMed Web of Science ®Google Scholar
• Chace DH, Spitzer AR. Altered metabolism and newborn screening using tandem mass spectrometry: lessons learned from the bench to bedside. Curr Pharm Biotechnol 2011;12(7):965-75
   PubMed Web of Science ®Google Scholar
• Gowda GA, Zhang S, Gu H, et al. Metabolomics-based methods for early disease diagnostics. Expert Rev Mol Diagn 2008;8(5):617-33
   PubMed Web of Science ®Google Scholar
• Prieto L, Quesada JF, Cambero O, et al. Analysis of follicular fluid and serum markers of oxidative stress in women with infertility related to endometriosis. Fertil Steril 2012;98(1):126-30
   PubMed Web of Science ®Google Scholar
• Khanaki K, Nouri M, Ardekani AM, et al. Evaluation of the relationship between endometriosis and omega-3 and omega-6 polyunsaturated fatty acids. Iran Biomed J 2012;16(1):38-43
   PubMedGoogle Scholar
• Vouk K, Hevir N, Ribic-Pucelj M, et al. Discovery of phosphatidylcholines and sphingomyelins as biomarkers for ovarian endometriosis. Hum Reprod 2012;27(10):2955-65
   PubMed Web of Science ®Google Scholar
• Dutta M, Joshi M, Srivastava S, et al. A metabonomics approach as a means for identification of potential biomarkers for early diagnosis of endometriosis. Mol Biosyst 2012;8(12):3281-7
   PubMedGoogle Scholar
• Olkowska-Truchanowicz J, Bocian K, Maksym RB, et al. CD4(+) CD25(+) FOXP3(+) regulatory T cells in peripheral blood and peritoneal fluid of patients with endometriosis. Hum Reprod 2013;28(1):119-24
   PubMed Web of Science ®Google Scholar
• Yang H, Lang JH, Zhu L, et al. Diagnostic value of the neutrophil-to-lymphocyte ratio and the combination of serum CA-125 for stages III and IV endometriosis. Chin Med J (Engl) 2013;126(11):2011-14
   PubMed Web of Science ®Google Scholar
• Yang H, Zhu L, Wang S, et al. Noninvasive Diagnosis of Moderate to Severe Endometriosis: The Platelet-Lymphocyte Ratio Cannot Be a Neoadjuvant Biomarker for Serum Cancer Antigen 125. J Minim Invasive Gynecol. 2013. [Epub ahead of print]
   Google Scholar
• Nnoaham KE, Hummelshoj L, Kennedy SH, et al. Consortium WERFWsHSS. Developing symptom-based predictive models of endometriosis as a clinical screening tool: results from a multicenter study. Fertil Steril 2012;98(3):692-701. e695
   PubMed Web of Science ®Google Scholar
• May KE, Villar J, Kirtley S, et al. Endometrial alterations in endometriosis: a systematic review of putative biomarkers. Hum Reprod Update 2011;17(5):637-53
   PubMed Web of Science ®Google Scholar
• Spielmann N, Wong DT. Saliva: diagnostics and therapeutic perspectives. Oral Dis 2011;17(4):345-54
   PubMed Web of Science ®Google Scholar
• Chandramouli K, Qian PY. Proteomics: challenges, techniques and possibilities to overcome biological sample complexity. Hum Genomics Proteomics 2009;2009
   PubMedGoogle Scholar
• Meehan KL, Rainczuk A, Salamonsen LA, Stephens AN. Proteomics and the search for biomarkers of female reproductive diseases. Reproduction 2010;140(4):505-19
   PubMed Web of Science ®Google Scholar
• Siristatidis CS. What have the ’omics done for endometriosis? Med Sci Monit 2009;15(5):RA116-23
   Google Scholar
• Zondervan KT, Cardon LR, Kennedy SH. What makes a good case-control study? Design issues for complex traits such as endometriosis. Hum Reprod 2002;17(6):1415-23
   PubMed Web of Science ®Google Scholar
• D’Hooghe TM, Mihalyi AM, Simsa P, et al. Why we need a noninvasive diagnostic test for minimal to mild endometriosis with a high sensitivity. Gynecol Obstet Invest 2006;62(3):136-8
   PubMed Web of Science ®Google Scholar
• Griffith CS, Grimes DA. The validity of the postcoital test. Am J Obstet Gynecol 1990;162(3):615-20
   PubMed Web of Science ®Google Scholar